Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. (Q47817407)

5 February 2018

title

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. (English)

1 reference

5 February 2018

0 references

Yiping Yang

1

1 reference

5 February 2018

Ching-Tai Huang

series ordinal

2

1 reference

5 February 2018

Xiaopei Huang

series ordinal

3

1 reference

5 February 2018

Drew M Pardoll

series ordinal

4

1 reference

5 February 2018

language of work or name

English

0 references

publication date

4 April 2004

1 reference

5 February 2018

number of pages

8

1 reference

inferred from page(s)

published in

Nature Immunology

1 reference

5 February 2018

volume

5

1 reference

5 February 2018

page(s)

508-515

1 reference

5 February 2018

issue

5

1 reference

5 February 2018

Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation

cites work

1 reference

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance

21 January 2018

1 reference

Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice

21 January 2018

1 reference

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

21 January 2018

1 reference

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

21 January 2018

1 reference

Dendritic cells as adjuvants for immune-mediated resistance to tumors

21 January 2018

1 reference

Spinning molecular immunology into successful immunotherapy

21 January 2018

1 reference

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

21 January 2018

1 reference

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

21 January 2018

1 reference

Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases

21 January 2018

1 reference

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters

21 January 2018

1 reference

Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin

21 January 2018

1 reference

Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model

21 January 2018

1 reference

Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (ALVAC) cytokine gene delivery induces destruction of established prostate tumors

21 January 2018

1 reference

CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells

21 January 2018

1 reference

Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen.

21 January 2018

1 reference

Mouse and human dendritic cell subtypes

21 January 2018

1 reference

Dendritic cells in immunity and tolerance-do they display opposite functions?

21 January 2018

1 reference

The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens

21 January 2018

1 reference

CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo

21 January 2018

1 reference

CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

21 January 2018

1 reference

Toll-like receptors and innate antiviral responses

21 January 2018

1 reference

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

21 January 2018

1 reference

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

21 January 2018

1 reference

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

21 January 2018

1 reference

Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines

21 January 2018

1 reference

Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity

21 January 2018

1 reference

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

21 January 2018

1 reference

Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma

21 January 2018

1 reference

7 January 2021

1 reference

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

7 January 2021

Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes

1 reference

7 January 2021

In vivo CD4+ T cell tolerance induction versus priming is independent of the rate and number of cell divisions

1 reference

7 January 2021

CD4+ T Cells Pass Through an Effector Phase During the Process of In Vivo Tolerance Induction

1 reference

7 January 2021

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

7 January 2021

Development of a self-inactivating lentivirus vector.

1 reference

7 January 2021

Identifiers

DOI

10.1038/NI1059

1 reference

5 February 2018

PubMed ID

15064759

1 reference

5 February 2018